13F Portfolios

Saturn V Capital Management LP: JAZZ PHARMACEUTICALS PLC (JAZZ): Quarterly 13F Position History

As of Q1 2026, Saturn V Capital Management LP reported 162,961 shares of JAZZ PHARMACEUTICALS PLC (JAZZ), worth $30.8M and representing 5.6% of its 13F equity book. Quarter-over-quarter share count change: 85,109 (-34.3%) . The position first appeared in Q2 2025 and has been disclosed across 4 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 4 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 162,961 85,109 -34.3% $30.8M 5.6% $189.1
Q4 2025 248,070 52,540 -17.5% $42.2M 7.7% $170.0
Q3 2025 300,610 +93,658 +45.3% $39.6M 8.7% $131.8
Q2 2025 206,952 $22.0M 8.9% $106.1

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Saturn V Capital Management LP first disclose a JAZZ position in 13F-HR filings?

Saturn V Capital Management LP first reported JAZZ PHARMACEUTICALS PLC (JAZZ) on its 13F-HR filing for the period ending 2025-06-30 (Q2 2025). The position has appeared on 4 reported quarters within Pactolio's tracked window.

What was Saturn V Capital Management LP's most recent quarter-over-quarter share-count change in JAZZ?

Between Q4 2025 and Q1 2026, Saturn V Capital Management LP reduced its JAZZ position by 85,109 shares (-34.3%), leaving 162,961 shares at a market value of $30.8M.

Does the implied price-per-share represent Saturn V Capital Management LP's cost basis in JAZZ?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.